These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1504019)

  • 1. Discordant transforming growth factor beta 1 RNA and protein localization during chemical carcinogenesis of the skin.
    Fowlis DJ; Flanders KC; Duffie E; Balmain A; Akhurst RJ
    Cell Growth Differ; 1992 Feb; 3(2):81-91. PubMed ID: 1504019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion.
    Cui W; Kemp CJ; Duffie E; Balmain A; Akhurst RJ
    Cancer Res; 1994 Nov; 54(22):5831-6. PubMed ID: 7954410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
    Weeks BH; He W; Olson KL; Wang XJ
    Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
    Go C; Li P; Wang XJ
    Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing.
    Kane CJ; Hebda PA; Mansbridge JN; Hanawalt PC
    J Cell Physiol; 1991 Jul; 148(1):157-73. PubMed ID: 1907288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C; Schirmacher P; Weber H; Blessing M
    Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis.
    Gold LI; Jussila T; Fusenig NE; Stenbäck F
    J Pathol; 2000 Apr; 190(5):579-88. PubMed ID: 10727984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
    Wach S; Schirmacher P; Protschka M; Blessing M
    Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
    Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
    Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
    Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
    Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ
    Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.
    Werner S; Beer HD; Mauch C; Lüscher B; Werner S
    Oncogene; 2001 Nov; 20(51):7494-504. PubMed ID: 11709721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.
    Braun L; Gruppuso P; Mikumo R; Fausto N
    Cell Growth Differ; 1990 Mar; 1(3):103-11. PubMed ID: 1964076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.